Filippini G, Kruja J, Del Giovane C
Cochrane Database Syst Rev. 2025; 3:CD013874.
PMID: 40066932
PMC: 11895426.
DOI: 10.1002/14651858.CD013874.pub3.
Marastoni D, Sicchieri M, Pizzini F, Scartezzini A, Virla F, Turano E
J Neurol. 2025; 272(3):207.
PMID: 39954124
PMC: 11829897.
DOI: 10.1007/s00415-025-12947-y.
Muller J, Sharmin S, Lorscheider J, Horakova D, Kubala Havrdova E, Eichau S
CNS Drugs. 2025; 39(4):403-416.
PMID: 39953338
DOI: 10.1007/s40263-025-01164-w.
Szekely-Kohn A, Castellani M, M Espino D, Baronti L, Ahmed Z, Manifold W
R Soc Open Sci. 2025; 12(1):241052.
PMID: 39845718
PMC: 11750376.
DOI: 10.1098/rsos.241052.
Hazim A, Mimouni Y, Hakimi M, Saaf S, El Azhari M, El Yakoubi Z
Cureus. 2025; 16(12):e75226.
PMID: 39759672
PMC: 11700539.
DOI: 10.7759/cureus.75226.
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.
Oechtering J, Schaedelin S, Stein K, Maceski A, Melie-Garcia L, Benkert P
Neurol Neuroimmunol Neuroinflamm. 2025; 12(2):e200361.
PMID: 39752618
PMC: 11702906.
DOI: 10.1212/NXI.0000000000200361.
A computational approach to drug design for multiple sclerosis via QSPR modeling, chemical graph theory, and multi-criteria decision analysis.
Farooq F, Idrees N, Noor E, Alqahtani N, Imran M
BMC Chem. 2025; 19(1):1.
PMID: 39748369
PMC: 11697749.
DOI: 10.1186/s13065-024-01374-1.
Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female Sex.
Vlad B, Hilty M, Neidhart S, Asplund Hogelin K, Ziegler M, Khademi M
Antibodies (Basel). 2024; 13(4).
PMID: 39727485
PMC: 11672439.
DOI: 10.3390/antib13040102.
[Effectiveness and tolerance of azathioprine as first-line treatment for multiple sclerosis: a case study from Morocco].
Mirhani A, Auajjar N, Slimani C, Attarassi B
Pan Afr Med J. 2024; 49:16.
PMID: 39711832
PMC: 11662217.
DOI: 10.11604/pamj.2024.49.16.38051.
Azathioprine for people with multiple sclerosis.
Ridley B, Nonino F, Baldin E, Casetta I, Iuliano G, Filippini G
Cochrane Database Syst Rev. 2024; 12:CD015005.
PMID: 39651635
PMC: 11626701.
DOI: 10.1002/14651858.CD015005.pub2.
Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
Kooshki A, Farmani R, Amirabadizadeh A, Mehrpour O, Sanjari M, Nakhaee S
PLoS One. 2024; 19(12):e0313851.
PMID: 39642137
PMC: 11623488.
DOI: 10.1371/journal.pone.0313851.
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis.
Krajnc N, Hofer L, Fottinger F, Dal-Bianco A, Leutmezer F, Kornek B
Eur J Neurol. 2024; 32(1):e16529.
PMID: 39529542
PMC: 11622274.
DOI: 10.1111/ene.16529.
NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.
Sandi D, Kokas Z, Kincses Z, Fuvesi J, Fricska-Nagy Z, Voros E
Heliyon. 2024; 10(20):e39536.
PMID: 39502229
PMC: 11535987.
DOI: 10.1016/j.heliyon.2024.e39536.
Effectiveness of Non-Pharmacological Interventions for Spasticity Management in Multiple Sclerosis: A Systematic Review.
Amatya B, Khan F, Song K, Galea M
Ann Rehabil Med. 2024; 48(5):305-343.
PMID: 39497494
PMC: 11540453.
DOI: 10.5535/arm.240064.
Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
Saboya-Galindo P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez C, Boada-Robayo L, Mendez-Marulanda R
PLoS One. 2024; 19(10):e0307455.
PMID: 39453915
PMC: 11508149.
DOI: 10.1371/journal.pone.0307455.
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.
Rocca M, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N
Lancet Reg Health Eur. 2024; 44:100978.
PMID: 39444702
PMC: 11496980.
DOI: 10.1016/j.lanepe.2024.100978.
Fluid biomarkers in multiple sclerosis: from current to future applications.
Di Filippo M, Gaetani L, Centonze D, Hegen H, Kuhle J, Teunissen C
Lancet Reg Health Eur. 2024; 44:101009.
PMID: 39444698
PMC: 11496979.
DOI: 10.1016/j.lanepe.2024.101009.
Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue.
Gakh O, Wilkins J, Guo Y, Popescu B, Weigand S, Kalinowska-Lyszczarz A
Acta Neuropathol Commun. 2024; 12(1):146.
PMID: 39256864
PMC: 11385516.
DOI: 10.1186/s40478-024-01854-4.
Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis.
Wu J, Yang J, Hu J, Xu S, Zhang X, Qian S
Front Immunol. 2024; 15:1429895.
PMID: 39229262
PMC: 11369894.
DOI: 10.3389/fimmu.2024.1429895.
Multiple sclerosis in Central America and Caribbean countries: frequency and clinical characterization of an emergent disease.
Gracia F, Ramirez Navarro D, Sanchez N, Weiser R, Parajeles-Vindas A, Rivera L
Front Epidemiol. 2024; 4:1368675.
PMID: 38952354
PMC: 11216161.
DOI: 10.3389/fepid.2024.1368675.
